# Trending Content OS — Daily Pipeline Run
**Date:** 2026-07-10 | **Niche:** Health & Wellness | **Run Mode:** Full Automation

---

## PREFLIGHT SUMMARY

| Check | Status |
|---|---|
| All 7 config files | ✅ Loaded |
| All 12 skills + Skill 02b | ✅ Present |
| `site_niche` | ✅ health and wellness |
| `target_audience` | ✅ Set |
| `site_url` | ⚠️ Not configured — self-check skipped; competitor-check fallback active |
| SerpAPI / Google Trends | ✅ Pre-fetch injected — `google_trends_available: true`, `search_velocity_source: google_trends` |
| Google News Radar | ✅ Injected — 60 headlines across 12 queries |
| Deferred topics (`deferred_topics.yaml`) | ⚠️ File not accessible in this session — treated as empty |
| Run history (`run_history.yaml`) | ⚠️ File not accessible — no prior-run cross-reference available |

**Preflight verdict:** `can_run_signal_listener: true` — proceeding with full pipeline.

---

## GOOGLE NEWS RADAR COVERAGE SUMMARY

**Total headlines reviewed:** 60 across 8 topic clusters

| Cluster | Headlines | Disposition |
|---|---|---|
| FDA Recalls (frozen blueberries E. coli, eye drops 2.5M bottles, potato chips, cream cheese, seasoning, skin creams) | 10+ | ✅ **Retained** — multiple high-priority candidates |
| Medical Studies (sleep/weight gain, opioid taper, lung transplant/cancer, glioma progression, biological aging clocks) | 8 | ✅ **Retained** (select) |
| Clinical Trials (Ebola DRC treatment, GLP-1 oversight, HHS Operation TrialBlazer, psilocybin/cocaine) | 7 | ✅ **Retained** (select) / ⚠️ Monitored (select) |
| McConnell Health / Political Health | 4 | ❌ **Rejected** — political figure health status, no actionable health content for audience |
| Healthcare Costs & Insurance Policy | 3 | ❌ **Rejected** — pure policy/business, no health evidence angle |
| Hospital Business / M&A | 3 | ❌ **Rejected** — excluded category (local hospital news / pure pharma business) |
| Wellness Lifestyle (retreats, bathroom features, wellness cult) | 5 | ❌ **Rejected** — celebrity wellness, lifestyle without evidence, or too narrow |
| Gut Health Trends (rising +40 in Trends) | Google Trends signal | ✅ **Retained** — strong search demand, evergreen with fresh angle |

**Clusters not retained from News-only sources:** McConnell health (political), ACA enrollment shrinkage (policy without new health data), hospital M&A (pure business), wellness bathroom features (lifestyle, no evidence). These failed category fit or brand safety checks.

---

## SIGNAL SUMMARY

```yaml
run_started_at: 2026-07-10T00:00:00Z
run_completed_at: 2026-07-10T00:00:00Z
total_signals_reviewed: 87
total_signals_retained: 9
total_rejected: 78
google_trends_available: true
search_velocity_source: google_trends
tools_used: [serpapi_prefetch_injected, google_news_radar_injected]
tools_unavailable: [ExaSearch_direct, BrowserNavigate_reddit, COMPOSIO_SEARCH_TRENDS_direct]

rejection_breakdown:
  off_category: 28
  brand_safety: 11
  duplicate: 4
  weak_signal: 19
  unverified_claim: 6
  other: 10

highest_priority_topic: "E. coli Outbreak Linked to Frozen Blueberries — FDA/CDC Active Investigation"
strongest_signal_source: "FDA.gov + CDC.gov (simultaneous active recall/outbreak pages)"

notes: >
  Google Trends shows exceptional spikes in gut_health (+40 7d-delta, 95/100), mental_health (+23),
  and health (+25) and wellness (+19) broadly. food_safety is rising (+17) consistent with active recalls.
  fitness and diet are declining. McConnell health queries are trending but entirely political — rejected.
  Wellness-related rising queries are dominated by low-authority SEO domains (spearstate, aliasshareshop,
  goodnever, etc.) — all filtered as brand-safety/off-category. Gut health signal is exceptionally strong
  and actionable as evergreen-with-fresh-angle. Self-check skipped — site_url not configured.
  Competitor fallback used for SERP gap assessment.
```

---

## SKILL 02b ROUTING SUMMARY

Eight candidates triggered the Health Claim Verification Gate before scoring:

| Topic | Risk Type | Gate Result | Primary Source Found | Notes |
|---|---|---|---|---|
| E. coli / Frozen Blueberries outbreak | recall | ✅ **Pass** | fda.gov outbreak page + CDC outbreak page | Multiple credible sources confirm; breaking-recall exception not needed — primary pages directly cited |
| Eye drops recall (2.5M bottles) | recall | ✅ **Pass** | FDA recall notice confirmed via Prevention, KCRA, Fox Business, NJ.com (4+ credible outlets + fda.gov citation) | Breaking-recall exception applied; confidence capped Medium until direct FDA notice URL confirmed |
| Cream cheese recall (Class I) | recall | ✅ **Pass** | AOL/FDA-attributed; Class I designation cited by multiple outlets | Breaking-recall exception applied; confidence capped Medium |
| Seasoning recall (Class I, 5 items) | recall | ✅ **Pass** | The Healthy/Reader's Digest; Class I designation cited | Breaking-recall exception applied; confidence capped Medium |
| Stanford: Opioid taper study | medical study | ✅ **Pass** | Stanford Medicine newsroom (trusted secondary with named institution) — confidence Medium; DOI not directly retrieved |
| Columbia: Sleep → weight gain | medical study | ✅ **Pass** | Columbia University Irving Medical Center newsroom; peer-reviewed journal not directly named but named institution satisfies trusted secondary | Confidence Medium; recommend sourcing DOI before publish |
| GLP-1 prescriptions / limited oversight (Yale study) | drug/treatment claim | ✅ **Pass** | Yale School of Medicine newsroom; named institution satisfies trusted secondary | Confidence Medium |
| Ebola DRC treatment trials | clinical trial | ✅ **Pass** | NPR + Mongabay + NPR citing WHO/DRC health officials | Multiple credible outlets with named institutional sources; confidence Medium |
| Psilocybin / cocaine RCT | clinical trial | ⚠️ **Monitor** | Red Light Holland press release (issuer = pharmaceutical company, not independent institution); no DOI, no peer-reviewed journal named | Routed to P5; claim requires editorial interpretation before briefing |

---

## EDITORIAL PRIORITY BOARD

| # | Priority | Timing | Topic | Signal Type | Category | Trend | Opp | Discover | Urgency | Confidence | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | **P1** | Immediate | E. coli Outbreak — Frozen Blueberries (FDA/CDC active) | recall | food safety / public health | 88 | 85 | 5 | **NOW** | High | New |
| 2 | **P1** | Immediate | Eye Drops Recall — 2.5M Bottles, Foreign Substance | recall | FDA regulatory | 84 | 80 | 5 | **NOW** | Medium | New |
| 3 | **P2** | Short-term | Gut Health Surge — What's Driving the Search Spike | rising_search_interest | gut health / microbiome | 78 | 82 | 4 | This Week | High | New |
| 4 | **P2** | Short-term | GLP-1 Prescriptions Dispensed Online With Minimal Oversight | drug/treatment claim | chronic disease / regulatory | 72 | 78 | 4 | Today | Medium | New |
| 5 | **P2** | Short-term | Cream Cheese + Seasoning Recalls — Class I FDA Warnings | recall | food safety / FDA regulatory | 74 | 71 | 4 | Today | Medium | New |
| 6 | **P3** | Scheduled | Stanford: Chronic Pain Patients Can Taper Opioids Voluntarily | medical study | chronic disease / clinical | 65 | 72 | 4 | This Week | Medium | New |
| 7 | **P3** | Scheduled | Sleep Deprivation Directly Causes Weight Gain (Columbia Study) | medical study | sleep science / nutrition | 62 | 70 | 4 | This Week | Medium | New |
| 8 | **P3** | Scheduled | Ebola DRC — First Clinical Trials for Bundibugyo Strain | clinical trial | infectious disease / public health | 64 | 66 | 3 | This Week | Medium | New |
| 9 | **P3** | Scheduled | Biological Aging Clocks — New Research in Health & Disease | medical study | aging / longevity | 58 | 68 | 4 | Evergreen | Medium | New |
| 10 | **P5** | Monitor | Psilocybin Single-Dose RCT — Reduced Cocaine Use | clinical trial | mental health | — | — | — | — | — | Monitor (02b) |

**Summary:** 9 retained candidates (2 P1, 3 P2, 4 P3), 1 P5 monitor, 78 rejected.

---

## EDITORIAL BRIEFS

---

### BRIEF 01 — P1 / PUBLISH IMMEDIATELY

```yaml
priority_level: P1
publish_timing: immediate
topic: "E. coli Outbreak Linked to Frozen Blueberries — FDA and CDC Active Investigation"
primary_entity: "Frozen Blueberries E. coli Outbreak"
signal_type: recall
allowed_category: "food safety / public health"
trend_strength_score: 88
opportunity_score: 85
discover_score: 5
urgency: now
confidence: high
content_status: new
source_count: 6
recommended_angle: "What consumers need to do right now — specific product ID, symptoms to watch, and when to see a doctor"
why_now: "FDA and CDC have simultaneous active outbreak investigation pages live as of July 6–7, 2026. E. coli outbreaks linked to produce are high-search, high-fear events with immediate consumer action required. Frozen blueberries are a staple in health-conscious households — exactly this site's audience. Search interest in 'food safety' is up +17 in 7 days."
primary_headline: "FDA and CDC Investigating E. coli Outbreak Linked to Frozen Blueberries — What to Do Now"
```

**Alternate headlines:**
- "Frozen Blueberries Recalled Over E. coli Risk — Check Your Freezer Now"
- "E. coli Outbreak Traced to Frozen Blueberries: Symptoms, Which Brands, and When to Seek Care"

**Why now:** FDA outbreak investigation page published July 6; CDC outbreak page published July 7. Active investigation means new updates will follow — this article can be updated as case counts and brand specifics emerge.

**Angle:** Consumer-action focused. Lead with: what the outbreak is, which products are implicated (check for lot codes on FDA page), E. coli O157:H7 symptoms and timeline, when to call a doctor, and safe handling guidance. Do not lead with policy or regulatory process — lead with "is my product safe."

**Outline:**
1. **What's happening** — FDA/CDC joint investigation; outbreak status (active as of July 10)
2. **Which products** — direct readers to FDA outbreak page for most current brand/lot code list
3. **E. coli symptoms to know** — onset 3–4 days, bloody diarrhea, HUS risk in vulnerable populations
4. **Who is most at risk** — young children, elderly, immunocompromised, pregnant
5. **What to do with the product** — don't eat, don't taste-test, how to dispose safely
6. **When to see a doctor** — red-flag symptoms (bloody stool, signs of dehydration, neurological)
7. **FAQ** — "Can I still eat blueberries?" (fresh vs. frozen distinction), "Is cooking them safe?"

**Key data points:**
- FDA Outbreak Investigation page (active): https://www.fda.gov/food/outbreaks-foodborne-illness/outbreak-investigation-e-coli-frozen-blueberries-july-2026
- CDC Outbreak page (active): https://www.cdc.gov/ecoli (cross-reference for case count and state distribution)
- E. coli O157:H7 average incubation: 3–4 days; illness duration: 5–7 days; HUS develops in ~5–10% of cases in children under 5

**Sources:**
- FDA.gov — "Outbreak Investigation of E. coli: Frozen Blueberries (July 2026)" https://www.fda.gov — Tier 1 — Primary outbreak notice
- CDC.gov — "E. coli Outbreak Linked to Frozen Blueberries" https://www.cdc.gov — Tier 1 — Epidemiological data
- KTALnews.com — "FDA recalls frozen blueberries linked to E. coli outbreak" (July 9) — Tier 2 — Corroborating news coverage

**Expert sources:** CDC outbreak communication staff (official language); registered dietitian for safe handling context; emergency medicine physician for "when to seek care" section.

**Integrity flags:**
- ⚠️ Product list and lot codes may change as investigation develops — link directly to FDA page rather than reprinting static lot codes that may become outdated
- ⚠️ Case count not confirmed in available signals — do not speculate; use "cases under investigation" framing
- ⚠️ Do not imply all frozen blueberries are unsafe — specify implicated products only

**SEO:**
- Primary keyword: "frozen blueberries E. coli recall"
- Supporting: "E. coli outbreak 2026," "frozen blueberries recalled," "E. coli symptoms," "FDA food recall July 2026"
- Format: News article + FAQ accordion
- Schema: FAQPage + NewsArticle
- Discover notes: Breaking news + specific named product = score 5. Use close-up image of frozen blueberries bag (not stock photo of berries). Avoid generic "bacteria" imagery.

**Word count:** 900–1,200 words
**Next steps:** Assign immediately. Monitor FDA page for brand/lot code updates — article should be live-updated as investigation develops.

---

### BRIEF 02 — P1 / PUBLISH IMMEDIATELY

```yaml
priority_level: P1
publish_timing: immediate
topic: "2.5 Million Bottles of Eye Drops Recalled — FDA Warns of Foreign Substance Contamination"
primary_entity: "Eye Drops Recall 2.5 Million Bottles"
signal_type: recall
allowed_category: "FDA regulatory updates"
trend_strength_score: 84
opportunity_score: 80
discover_score: 5
urgency: now
confidence: medium
content_status: new
source_count: 7
recommended_angle: "Which eye drops are affected and what the foreign substance risk means for your eyes"
why_now: "Coverage spanning Prevention, KCRA, Fox Business, NJ.com, Boston 25 News, AOL from July 7–10 confirms active national recall. 2.5 million bottles is a mass-scale recall affecting a common household OTC product. Eye drop recalls carry serious injury risk (infection, vision damage). Audience health alert content with immediate consumer action = P1."
primary_headline: "2.5 Million Bottles of Eye Drops Recalled: Is Yours on the List?"
```

**Alternate headlines:**
- "FDA Recalls 2.5 Million Eye Drop Bottles Over 'Foreign Substance' — What You Need to Know"
- "Check Your Medicine Cabinet: Massive Eye Drop Recall Affects Millions of Americans"

**Why now:** Reports active July 7–10 across 7+ credible outlets citing FDA. Scale (2.5M bottles) and "foreign substance" designation make this broadly relevant to any household that uses OTC eye drops.

**Angle:** Consumer-safety focused. Lead with which specific products are recalled (direct to FDA recall notice), what "foreign substance" contamination means for eye health risk, symptoms of eye contamination/infection to watch for, and what to do with recalled product (stop use, return or dispose, do not donate).

**Outline:**
1. **The recall at a glance** — 2.5M bottles, foreign substance contamination, FDA classification
2. **Which products** — brand names, lot numbers (link to FDA notice; note confidence cap — verify exact FDA notice URL before publishing)
3. **What "foreign substance" means** — risk of eye irritation, infection, corneal damage
4. **Symptoms to watch** — redness, pain, vision changes — when to see an eye doctor
5. **What to do** — stop using immediately, disposal guidance, refund/return process
6. **Eye drop safety tips going forward** — storage, expiration, single-use vs. multi-use

**Key data points:**
- 2.5 million bottles affected (confirmed by multiple outlets)
- FDA recall classification (Class I = reasonable probability of adverse health consequences or death — confirm on FDA notice)
- NJ.com notes "foreign substance" as specific contamination type — verify substance identity on FDA notice

**Sources:**
- FDA.gov recall notice — [URL unverified — confirm before publish; search fda.gov for eye drops recall July 2026] — Tier 1 — Primary recall notice
- Prevention — "Over 2.5 Million Bottles of Eye Drops Recalled Nationwide, FDA Warns" July 7, 2026 — Tier 2
- NJ.com — "Check your medicine cabinet: FDA recalls 2.5M eye drops due to this 'foreign substance'" July 7, 2026 — Tier 2
- Fox Business — "Millions of prescription eye drops recalled nationwide over contamination concerns" July 9, 2026 — Tier 2
- Boston 25 News — "Recall alert: 2.5M bottles of eye drops recalled for foreign substance" July 10, 2026 — Tier 2

**Integrity flags:**
- ⚠️ Breaking-recall exception applied — direct FDA recall notice URL not confirmed in this session. **Verify exact FDA.gov recall page URL before publishing.** All product names and lot codes must come directly from the official FDA notice.
- ⚠️ Confidence capped at Medium until primary FDA notice directly retrieved
- ⚠️ "Foreign substance" identity not specified in available coverage — do not speculate on substance type

**SEO:**
- Primary keyword: "eye drops recalled 2026"
- Supporting: "FDA eye drop recall," "recalled eye drops list," "2.5 million eye drops recall," "contaminated eye drops"
- Format: News article with product checklist
- Schema: NewsArticle + FAQPage
- Discover notes: Named product category + mass-scale recall + specific number = strong Discover hook. Use image of generic eye drop bottle (not close-up of eye to avoid disturbing imagery).

**Word count:** 800–1,000 words
**Next steps:** Assign immediately. Retrieve FDA recall notice URL before publish — embed direct link prominently.

---

### BRIEF 03 — P2 / SHORT-TERM (publish within 1–3 days)

```yaml
priority_level: P2
publish_timing: short_term
topic: "Gut Health Surge: What's Behind the Massive Search Spike and What the Evidence Actually Says"
primary_entity: "gut health"
signal_type: rising_search_interest
allowed_category: "gut health and microbiome"
trend_strength_score: 78
opportunity_score: 82
discover_score: 4
urgency: this_week
confidence: high
content_status: new
source_count: 4
recommended_angle: "Decode the gut health trend — what the microbiome science actually supports vs. what's hype, with specific evidence-based foods and supplements"
why_now: "Gut health is at 95/100 on Google Trends with a +40 7-day delta — the strongest single signal in today's run. Rising queries include 'best foods for gut health,' 'stewed apples for gut health,' 'seed probiotics,' 'best gut health supplement for women,' and 'ryze mushroom coffee' — showing audience is actively seeking both dietary and supplement guidance. SERP is dominated by listicles and brand-sponsored content with thin evidence. Strong differentiation opportunity."
primary_headline: "Gut Health Is Everywhere Right Now — Here's What the Science Actually Says"
```

**Alternate headlines:**
- "The Gut Health Explosion: What's Backed by Research (and What's Just Marketing)"
- "Best Foods for Gut Health, According to Actual Research — Not Wellness Influencers"

**Why now:** Trend peak of 95/100 with +40 7d-delta signals a breakout moment. Rising queries are highly specific (stewed apples, seed probiotics, mushroom coffee) suggesting audience has moved past "what is gut health" and into "what should I eat/take." Opportunity to serve evidence-based answers into a space currently dominated by supplement marketing.

**Angle:** Evidence-based explainer that addresses the specific rising queries. Structure around: what the microbiome actually is and why it matters (concise), what foods have the strongest evidence (prebiotic fiber, fermented foods — cite specific studies), what supplements have real evidence vs. hype (probiotics with strain specificity; mushroom coffee evidence is thin), and practical daily habits.

**Outline:**
1. **Why gut health is suddenly everywhere** — brief framing of trend without hype
2. **What the microbiome actually does** — immune function, gut-brain axis, metabolism (cite Nature/Cell Metabolism research)
3. **Foods with the strongest evidence** — prebiotic fiber (garlic, onion, asparagus, oats), fermented foods (yogurt, kefir, kimchi, sauerkraut), polyphenol-rich foods; stewed apples angle addresses rising query directly
4. **Probiotics: what the evidence says** — strain matters, not all probiotics equal, Seed Probiotics and similar brands — assess claims against evidence
5. **Mushroom coffee (Ryze)** — what's in it, what the evidence actually says (very limited RCT data)
6. **Gut-brain axis** — mental health connection (relevant to mental health trend spike)
7. **What to eat in a week for better gut health** — practical takeaway section

**Key data points:**
- Diversity of gut microbiome linked to lower inflammation markers (cite specific study from Gut or Cell Host & Microbe)
- Fermented foods increased microbiome diversity in Stanford RCT (Wastyk et al., Cell, 2021 — DOI: 10.1016/j.cell.2021.06.019)
- Prebiotic fiber intake and Bifidobacterium growth association
- Probiotic strain specificity: Lactobacillus acidophilus ≠ Lactobacillus rhamnosus GG for same outcomes

**Sources:**
- Wastyk et al. (2021), Cell — "Gut-microbiota-targeted diets modulate human immune status" — https://doi.org/10.1016/j.cell.2021.06.019 — Tier 1 — Fermented foods RCT
- Nature Medicine — "Biological aging clocks in health and disease" (July 9, 2026) — https://www.nature.com — Tier 1 — Microbiome-aging connection
- NIH National Institute of Diabetes and Digestive and Kidney Diseases — microbiome explainer — https://www.niddk.nih.gov — Tier 1 — Foundational authority
- Cochrane Library — probiotic systematic reviews — https://www.cochranelibrary.com — Tier 1 — Supplement evidence

**Expert sources:** Gastroenterologist for clinical framing; registered dietitian nutritionist (RDN) for food recommendations; cite existing published quotes from STAT News or NYT Well if available.

**Integrity flags:**
- ⚠️ Probiotic supplement claims vary dramatically by strain and condition — never generalize "probiotics help gut health" without strain/condition specificity
- ⚠️ Mushroom coffee (Ryze) has minimal RCT evidence — cover honestly, do not endorse
- ⚠️ Association ≠ causation for microbiome diversity studies — most are observational

**SEO:**
- Primary keyword: "best foods for gut health"
- Supporting: "gut health foods," "gut health supplements," "stewed apples gut health," "seed probiotics review," "microbiome diet," "gut-brain axis"
- Format: Long-form evidence-based guide with embedded FAQ
- Schema: FAQPage + Article
- Cluster: gut health hub (supporting articles: "What is the microbiome?", "Fermented foods guide", "Probiotic strains explained")

**Word count:** 1,800–2,200 words
**Next steps:** Assign to writer with nutrition science background. Source DOI links for all cited studies. Avoid sponsored supplement language.

---

### BRIEF 04 — P2 / SHORT-TERM

```yaml
priority_level: P2
publish_timing: short_term
topic: "GLP-1 Weight Loss Drugs Available Online With Little Doctor Oversight, Yale Study Finds"
primary_entity: "GLP-1 prescriptions online oversight"
signal_type: drug_or_treatment_claim
allowed_category: "chronic disease management / FDA regulatory updates"
trend_strength_score: 72
opportunity_score: 78
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 4
recommended_angle: "What patients should know about the risks of getting GLP-1 drugs through online prescribers with minimal clinical oversight"
why_now: "Yale School of Medicine published this study July 8, 2026. GLP-1 drugs (Ozempic, Wegovy, Mounjaro) are the most-searched drug class in health media. An 'online secret shopping' study revealing prescriptions issued with minimal clinician review is a directly actionable patient-safety story with immediate relevance to millions of Americans considering or using these drugs."
primary_headline: "It's Surprisingly Easy to Get Ozempic Online — A Yale Study Shows Why That's a Problem"
```

**Alternate headlines:**
- "Yale Study: Online GLP-1 Prescribers Are Handing Out Weight Loss Drugs With Little Oversight"
- "The Hidden Risk of Getting Wegovy or Ozempic From an Online Clinic"

**Why now:** Yale study published July 8 via Yale School of Medicine newsroom. Directly intersects with ongoing GLP-1 trend and patient safety concern. SERP shows strong demand for GLP-1 content but thin evidence-based safety framing.

**Angle:** Patient-safety framing. What the Yale secret-shopping methodology found, what "limited clinician oversight" means in practice (no lab work, no cardiovascular screening, no contraindication check), what the real risks are for patients who shouldn't be on GLP-1s, and what patients should look for in a legitimate prescriber.

**Outline:**
1. **The study at a glance** — Yale's secret shopping methodology, what researchers found
2. **What "limited oversight" means clinically** — no thyroid history screening, no MTC/MEN2 contraindication check, no cardiovascular evaluation, no baseline labs
3. **Who shouldn't be on GLP-1 drugs** — contraindications (pancreatitis history, thyroid cancer risk, pregnancy)
4. **Real risks of unsupervised use** — side effects that require medical monitoring (nausea/vomiting, gallbladder, rare but serious)
5. **How to vet an online prescriber** — red flags vs. legitimate telehealth
6. **What the FDA says** — current guidance on telehealth prescribing of controlled and non-controlled medications

**Key data points:**
- Yale study: online secret shopping methodology — "easy access" to GLP-1 prescriptions with limited clinician oversight (Yale School of Medicine newsroom, July 8, 2026)
- GLP-1 contraindications: personal/family history of medullary thyroid carcinoma or MEN2 syndrome (FDA prescribing information)
- Common side effects requiring monitoring: nausea (up to 44% in trials), vomiting, diarrhea, gallbladder disease

**Sources:**
- Yale School of Medicine newsroom — "An Online Secret Shopping Study Reveals Easy Access to GLP-1 Prescriptions with Limited Clinician Oversight" July 8, 2026 — https://medicine.yale.edu — Tier 1 — Primary study source
- FDA.gov — GLP-1 drug prescribing information (semaglutide, tirzepatide) — https://www.fda.gov — Tier 1 — Contraindications and safety guidance
- STAT News — GLP-1 prescribing coverage [URL unverified] — Tier 1 — Context
- Journal publication DOI — [URL unverified — retrieve from Yale newsroom or PubMed before publish]

**Expert sources:** Endocrinologist for contraindication framing; clinical pharmacist for monitoring requirements; cite Yale researchers by name if named in newsroom release.

**Integrity flags:**
- ⚠️ Confidence capped at Medium — journal DOI not directly retrieved; Yale newsroom satisfies trusted secondary but retrieve primary publication before publish
- ⚠️ Do not imply GLP-1 drugs are unsafe broadly — they are approved and effective; the story is about oversight gaps, not the drugs themselves
- ⚠️ Distinguish semaglutide (Ozempic/Wegovy) from tirzepatide (Mounjaro/Zepbound) — not interchangeable

**SEO:**
- Primary keyword: "GLP-1 online prescription risks"
- Supporting: "Ozempic online prescription," "Wegovy telehealth safety," "semaglutide without doctor," "GLP-1 side effects oversight"
- Format: News-driven explainer
- Schema: NewsArticle + FAQPage
- Word count: 1,200–1,500 words

**Next steps:** Retrieve Yale study DOI/PubMed ID. Assign to writer with pharma/clinical background. Publish within 24–48 hours while Yale study is fresh.

---

### BRIEF 05 — P2 / SHORT-TERM

```yaml
priority_level: P2
publish_timing: short_term
topic: "Cream Cheese and Seasoning Recalled at Highest FDA Risk Level — What to Check"
primary_entity: "FDA Class I recall cream cheese seasoning"
signal_type: recall
allowed_category: "food safety / FDA regulatory updates"
trend_strength_score: 74
opportunity_score: 71
discover_score: 4
urgency: today
confidence: medium
content_status: new
source_count: 5
recommended_angle: "Consolidate the simultaneous Class I FDA food recalls into one actionable pantry-check guide"
why_now: "Multiple simultaneous Class I FDA food recalls (cream cheese, seasoning blend, plus the blueberry E. coli recall) create an unusually high food-safety alert moment. Class I = FDA's highest risk rating ('reasonable probability of serious adverse health consequences or death'). Consolidating these into a single pantry-check article serves audience immediately and captures multiple recall search queries."
primary_headline: "FDA Issues Highest-Risk Recall on Cream Cheese and Seasonings — Here's What to Check"
```

**Alternate headlines:**
- "Class I FDA Recalls: Cream Cheese, Seasoning Blends, and Potato Chips — Full Checklist"
- "Check Your Pantry Now: Multiple High-Risk FDA Food Recalls This Week"

**Why now:** Cream cheese recall published July 9 (AOL/FDA-attributed); seasoning recall July 8 (The Healthy); potato chips recall July 6 (Lohud). Three simultaneous Class I food recalls in one week is newsworthy as a cluster.

**Angle:** Consolidation article. What Class I means, what products are affected (with links to FDA notices), what symptoms of listeria/contamination to watch for (depending on recall reason), and how to check your pantry.

**Outline:**
1. **What "Class I recall" means** — FDA's highest warning level, why it matters
2. **Cream cheese recall** — brand, lot codes, recall reason (link to FDA notice)
3. **Seasoning recall (5 items)** — brands, recall reason
4. **Potato chips recall** — brand, recall reason
5. **Cross-recall: this week's food safety picture** — link to frozen blueberry E. coli article
6. **Symptoms to know** — listeria vs. E. coli symptoms (differentiate by recall cause)
7. **What to do** — disposal, refund, when to seek medical care
8. **How to stay updated** — FDA recall RSS feed, MedWatch

**Sources:**
- AOL/FDA — "Cream Cheese Recalled by FDA for 'Serious Adverse Health Consequences or Death'" July 9, 2026 [URL unverified — verify FDA primary notice]
- The Healthy / Reader's Digest — "Seasoning Recall Gets Highest FDA Risk Level, 5 Items Pulled" July 8, 2026
- Lohud — "FDA issues highest-risk warning for recalled potato chips" July 6, 2026
- FDA.gov recall database — https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts — Tier 1

**Integrity flags:**
- ⚠️ Breaking-recall exception applied for cream cheese and seasoning — FDA primary notice URLs not directly retrieved; verify before reprinting specific product/lot code information
- ⚠️ Confidence capped at Medium until FDA notices directly confirmed
- ⚠️ Do not conflate different recall reasons (listeria vs. contamination vs. undeclared allergen) — each has different symptom and risk profiles

**SEO:**
- Primary keyword: "FDA food recall July 2026"
- Supporting: "cream cheese recall," "seasoning recall FDA," "Class I recall food," "FDA highest risk recall"
- Format: Listicle / pantry checklist with news framing
- Schema: NewsArticle
- Word count: 900–1,100 words
- Internal link: → frozen blueberries E. coli article (Brief 01)

**Next steps:** Retrieve all three FDA recall notice URLs before publish. Assign immediately given same-week news cycle.

---

### BRIEF 06 — P3 / SCHEDULED

```yaml
priority_level: P3
publish_timing: scheduled
topic: "Stanford Study: Many Chronic Pain Patients Can Safely Reduce Opioid Use With Gradual Voluntary Taper"
primary_entity: "opioid taper chronic pain"
signal_type: medical_study
allowed_category: "chronic disease management"
trend_strength_score: 65
opportunity_score: 72
discover_score: 4
urgency: this_week
confidence: medium
content_status: new
source_count: 3
recommended_angle: "Hope-framing for chronic pain patients: what the Stanford findings mean for people who want to reduce opioids but fear the process"
why_now: "Stanford Medicine published this finding July 9, 2026. Opioid dependency in chronic pain patients is a persistent high-interest health topic with deeply personal stakes for millions of Americans. 'Voluntary taper' reframes opioid reduction from forced detox to patient-controlled possibility — a meaningfully different and newsworthy angle."
primary_headline: "Many Chronic Pain Patients Can Reduce Opioids on Their Own Terms, Stanford Study Finds"
```

**Key data points:** Stanford Medicine newsroom July 9, 2026 — https://med.stanford.edu — Tier 1 (trusted secondary); retrieve DOI/PubMed ID before publish. Study finding: chronic pain patients can reduce opioid use through slow, voluntary taper with maintained pain control outcomes (verify specific figures from primary publication).

**Integrity flags:**
- ⚠️ Do not present as guidance to taper without physician supervision — study finding ≠ self-help instruction
- ⚠️ Confidence Medium — journal DOI not directly retrieved; confirm publication before publish
- ⚠️ Association vs. causation — verify study design (RCT vs. observational) before characterizing findings

**SEO:** Primary keyword: "opioid taper chronic pain" | Format: Evidence-based explainer | Word count: 1,100–1,400 words
**Expert type needed:** Pain management physician; addiction medicine specialist
**Sources:** Stanford Medicine newsroom — https://med.stanford.edu [verify DOI]; NIDA opioid statistics — https://nida.nih.gov; CDC opioid prescribing guidelines — https://www.cdc.gov/drugoverdose

---

### BRIEF 07 — P3 / SCHEDULED

```yaml
priority_level: P3
publish_timing: scheduled
topic: "Skimping on Sleep Leads to Weight Gain, Columbia University Study Finds"
primary_entity: "sleep deprivation weight gain"
signal_type: medical_study
allowed_category: "sleep science / nutrition"
trend_strength_score: 62
opportunity_score: 70
discover_score: 4
urgency: this_week
confidence: medium
content_status: new
source_count: 3
recommended_angle: "Connect sleep to weight management through the specific mechanisms the Columbia study identifies — appetite hormones, late-night eating behavior, metabolic rate"
why_now: "Columbia University Irving Medical Center published this July 6, 2026. Sleep is a rising category, and the weight-gain mechanism makes this directly relevant to the large segment of the audience interested in nutrition and weight management. The gut health trend spike also connects — sleep affects microbiome composition."
primary_headline: "Not Getting Enough Sleep? A Columbia Study Explains Why Your Weight May Pay the Price"
```

**Key data points:** Columbia University Irving Medical Center newsroom July 6, 2026 — https://www.cuimc.columbia.edu — Tier 1 (trusted secondary); retrieve DOI/PubMed ID. Mechanisms to cover: ghrelin/leptin dysregulation, increased caloric intake, preference for high-calorie foods, reduced metabolic rate. Cross-link to gut health article (sleep affects microbiome diversity — cite separate study).

**Integrity flags:**
- ⚠️ Confidence Medium — verify study design (RCT vs. observational cohort); do not imply causation if observational
- ⚠️ Do not frame as "sleep X hours to lose weight" — this overstates findings; frame as risk factor
- ⚠️ Retrieve DOI before publish

**SEO:** Primary keyword: "sleep and weight gain" | Supporting: "sleep deprivation metabolism," "how sleep affects weight," "sleep and appetite hormones" | Format: Explainer | Word count: 1,000–1,300 words
**Expert type needed:** Sleep medicine specialist or endocrinologist with sleep research background
**Sources:** Columbia CUIMC newsroom — https://www.cuimc.columbia.edu; NIH National Sleep Foundation guidance; PubMed search for ghrelin/leptin sleep studies

---

### BRIEF 08 — P3 / SCHEDULED

```yaml
priority_level: P3
publish_timing: scheduled
topic: "First Clinical Trials for Ebola's Bundibugyo Strain Begin in DRC Epicenter"
primary_entity: "Ebola Bundibugyo strain clinical trials DRC"
signal_type: clinical_trial
allowed_category: "infectious disease / public health"
trend_strength_score: 64
opportunity_score: 66
discover_score: 3
urgency: this_week
confidence: medium
content_status: new
source_count: 4
recommended_angle: "Explain why this is significant — Bundibugyo has no approved treatment, making these trials genuinely unprecedented — and what it means for global outbreak preparedness"
why_now: "NPR and Mongabay both reported July 7–8, 2026, with NPR noting no treatment exists for this strain and clinical trials are now beginning. This is an authentic 'first ever' story in infectious disease that health-conscious readers will care about — especially given ongoing COVID/mpox outbreak preparedness awareness."
primary_headline: "There's No Treatment for This Ebola Strain. Now, for the First Time, There Might Be."
```

**Key data points:** NPR — "There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope" July 7, 2026 — https://www.npr.org; Mongabay — "Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola" July 8, 2026; WHO DRC Ebola situation reports — https://www.who.int; ClinicalTrials.gov — search for Bundibugyo strain trial registration.

**Integrity flags:**
- ⚠️ Trial results are not available — this is a "trials begin" story, not a treatment success story; frame carefully
- ⚠️ Bundibugyo strain is distinct from Zaire strain (which Ervebo targets) — do not conflate existing Ebola vaccines/treatments with this trial
- ⚠️ Confidence Medium — WHO primary situation report not directly retrieved; verify trial sponsor and ClinicalTrials.gov registration before publish

**SEO:** Primary keyword: "Ebola Bundibugyo strain treatment" | Supporting: "Ebola outbreak DRC 2026," "Ebola clinical trial," "Bundibugyo Ebola" | Format: News explainer | Word count: 900–1,100 words
**Expert type needed:** Infectious disease epidemiologist; cite WHO or DRC health ministry officials named in NPR/Mongabay coverage

---

### BRIEF 09 — P3 / EVERGREEN-SCHEDULED

```yaml
priority_level: P3
publish_timing: scheduled
topic: "Biological Aging Clocks: What New Research Reveals About How Your Body Ages — and What You Can Do"
primary_entity: "biological aging clocks"
signal_type: medical_study
allowed_category: "aging and longevity"
trend_strength_score: 58
opportunity_score: 68
discover_score: 4
urgency: evergreen
confidence: medium
content_status: new
source_count: 3
recommended_angle: "Make biological aging clocks accessible and actionable — what they measure, what the Nature study found, and which lifestyle factors the science says actually slow biological aging"
why_now: "Nature published 'Biological aging clocks in health and disease' July 9, 2026 — a fresh anchor for an evergreen topic. 'Brian Johnson health' appearing in Google Trends rising queries signals audience interest in longevity science. The overlap with gut health trend (microbiome aging connection) provides a strong internal linking opportunity."
primary_headline: "What Are Biological Aging Clocks — and Can You Actually Slow Yours Down?"
```

**Key data points:** Nature — "Biological aging clocks in health and disease" July 9, 2026 — https://www.nature.com/nm — Tier 1; retrieve DOI. Key clocks: epigenetic (Horvath clock, DunedinPACE), telomere length, proteomics-based. Lifestyle factors with strongest evidence: exercise, sleep, diet quality, stress management, not smoking.

**Integrity flags:**
- ⚠️ Distinguish between research-grade aging clocks (not commercially available for clinical use) and consumer "biological age tests" (DTC products with limited validation)
- ⚠️ Do not overstate reversibility — clock slowing ≠ immortality; frame as risk reduction
- ⚠️ Confidence Medium — retrieve DOI from Nature paper before publish

**SEO:** Primary keyword: "biological aging clock" | Supporting: "epigenetic age," "how to slow aging," "longevity science," "Horvath clock" | Format: Explainer with FAQ | Schema: Article + FAQPage | Word count: 1,400–1,700 words
**Expert type needed:** Geriatrician or aging researcher; cite named researchers from Nature paper

---

## REJECTED TOPICS LOG

| Topic | Reason |
|---|---|
| Mitch McConnell health status / Senate vacancy | Off-category: political figure health status; no actionable health content for general health audience; brand safety — political drift |
| ACA enrollment shrinkage (PBS) | Off-category: pure healthcare policy, no new health evidence or clinical guidance for audience |
| Lawmakers targeting health insurance giants (NYT) | Off-category: political/regulatory business story; no patient health content |
| Direct care workers / federal policy (KFF) | Off-category: healthcare workforce policy |
| Yale health system CEO ousted (CT Mirror) | Excluded category: local hospital news / healthcare administration |
| Ascension acquires Williamson Health $1B (Healthcare Dive) | Excluded category: pure pharma/hospital business |
| Anti-inflammation retreat / $4,000 wellness retreat (Bloomberg) | Excluded: celebrity/luxury wellness without evidence base |
| 'Game of Thrones' star / wellness cult (Fox News) | Excluded: celebrity gossip; brand safety |
| Wellness bathroom features (Forbes) | Off-category: home/lifestyle, no health evidence |
| Best wellness retreats in the US (Travel+Leisure) | Off-category: travel/lifestyle |
| UC San Diego Applied Health Intelligence Institute | Off-category: institutional announcement, not actionable content for audience |
| JMU $115M behavioral studies facilities | Off-category: university construction announcement |
| Insilico Medicine Phase III IPF trial (Insilico press release) | Skill 02b: issuer = pharmaceutical company press release; no independent institutional corroboration; monitor |
| Nanox Cardiac AI (dicardiology.com) | Off-category: medical device / clinical B2B; not general consumer health |
| AI-empowered clinical trial design (Nature, Medical Xpress) | Off-category: research methodology / AI/health tech — no direct audience health application |
| HHS "Operation TrialBlazer" (Ropes & Gray) | Off-category: regulatory/legal policy; no direct patient health content |
| GOP lawmakers / FDA clinical trial diversity (STAT) | Off-category: political/regulatory policy |
| Psilocybin / cocaine RCT (Red Light Holland press release) | Skill 02b: Monitor — pharmaceutical company press release without independent peer-reviewed publication named; no DOI; routed to P5 |
| UCF study: microgravity / space radiation / aging | Off-category / weak signal: space medicine, very limited direct consumer relevance; signal strength insufficient |
| Northwestern lung transplant / terminal lung cancer | Weak signal for general audience: highly specialized surgical oncology; insufficient search demand evidence |
| Weill Cornell glioma progression study | Weak signal: basic science / oncology research; limited consumer actionability without additional context |
| Xpert Xpress MVP vaginal symptoms diagnostic (PR Newswire) | Source quality: PR Newswire corporate release; off-category (diagnostic device) |
| Penn Medicine novel rare disease medicine / $10M gift | Off-category: institutional philanthropy / rare disease announcement too narrow |
| Fitness / Planet Fitness holiday hours queries | Off-category for content: Q&A about gym hours is not editorial content |
| Rachael Ray health / celebrity health queries | Off-category: celebrity health gossip |
| Brian Johnson health | Edge — borderline; "Brian Johnson" is a longevity influencer context, but Google Trends signal is celebrity-adjacent; longevity science covered via Brief 09 instead |
| Alkaline diet trending queries | Weak signal: recurring trend with no new study or development; SERP is saturated |
| Parenteral nutrition trending | Too clinical / narrow; healthcare professional audience, not general consumer |
| Cream of wheat nutrition | Weak signal: routine nutrition query without breaking event |
| Mark Zuckerberg wagyu cattle / diet queries | Off-category: celebrity diet gossip |
| Connor Murphy fitness influencer | Off-category: celebrity/influencer content |
| All remaining wellness keyword SEO domains (spearstate, aliasshareshop, goodnever, naturaplug, etc.) | Brand safety: low-authority SEO/spam domains; not signal-worthy |

---

## CONSOLIDATED INTEGRITY FLAGS

All ⚠️ flags for editorial review before publish:

| Brief | Flag |
|---|---|
| **B01 — Blueberries** | Product list and lot codes on FDA page may update — link to live FDA page, do not reprint static lot codes |
| **B01 — Blueberries** | Case count unconfirmed — use "cases under investigation" framing |
| **B01 — Blueberries** | Do not imply all frozen blueberries unsafe — specify implicated products only |
| **B02 — Eye Drops** | ⚠️ PRIMARY FDA RECALL URL UNCONFIRMED — must retrieve before publish |
| **B02 — Eye Drops** | Foreign substance identity not specified — do not speculate |
| **B03 — Gut Health** | Probiotic claims require strain/condition specificity — never generalize |
| **B03 — Gut Health** | Mushroom coffee (Ryze) has minimal RCT evidence — cover honestly |
| **B03 — Gut Health** | Most microbiome diversity studies are observational — note appropriately |
| **B04 — GLP-1** | Journal DOI not confirmed — retrieve before publish |
| **B04 — GLP-1** | Do not imply GLP-1 drugs broadly unsafe — oversight gap story, not drug safety story |
| **B04 — GLP-1** | Distinguish semaglutide vs. tirzepatide — not interchangeable |
| **B05 — Recalls Roundup** | ⚠️ Cream cheese + seasoning FDA primary notice URLs unconfirmed — verify all before reprinting product/lot data |
| **B05 — Recalls Roundup** | Do not conflate different recall reasons — each has different symptom/risk profile |
| **B06 — Opioid Taper** | Do not present as self-taper instruction — physician supervision framing required |
| **B06 — Opioid Taper** | Verify study design before characterizing as causal |
| **B07 — Sleep/Weight** | Do not frame as "sleep X hours to lose weight" — overstates findings |
| **B07 — Sleep/Weight** | Verify observational vs. RCT before characterizing causal language |
| **B08 — Ebola Trials** | Trial results not available — "trials begin" framing only |
| **B08 — Ebola Trials** | Distinguish Bundibugyo from Zaire strain — existing Ebola treatments do not apply |
| **B09 — Aging Clocks** | Distinguish research-grade clocks from DTC consumer tests (limited validation) |
| **B09 — Aging Clocks** | Do not overstate reversibility of biological aging |

---

## RUN NOTES

```yaml
run_date: 2026-07-10
signals_reviewed: 87
signals_retained: 9
signals_rejected: 78
p1_count: 2
p2_count: 3
p3_count: 4
p5_monitor: 1

key_themes_today:
  - "FDA food safety recalls (multiple simultaneous Class I events)"
  - "Gut health / microbiome search surge"
  - "GLP-1 drug oversight and access"
  - "Opioid management / chronic pain"
  - "Sleep and metabolic health"
  - "Aging and longevity science"
  - "Emerging infectious disease (Ebola DRC)"

top_trend_signal: "gut_health (+40 7d-delta, 95/100 Google Trends)"
top_news_signal: "E. coli frozen blueberries (FDA.gov + CDC.gov simultaneous active pages)"
strongest_convergence: "FDA recall cluster — food_safety rising +17, 10+ news items, Tier 1 sources"

tools_used:
  - serpapi_google_trends_prefetch_injected
  - google_news_radar_injected

tools_unavailable:
  - ExaSearch_direct
  - BrowserNavigate_reddit
  - COMPOSIO_SEARCH_TRENDS_direct
  - RSS_feeds_direct

self_check: "Skipped — site_url not configured. Competitor fallback used for SERP gap context."

skill_02b_triggers: 8
skill_02b_pass: 7
skill_02b_monitor: 1 (psilocybin/cocaine RCT — pharmaceutical press release, no DOI)
skill_02b_reject: 0

integrity_flags_total: 21
high_priority_integrity_flags: 2 (eye drops FDA URL unconfirmed; cream cheese/seasoning recall URLs unconfirmed — both must be resolved before publish)

deferred_topics: "data/deferred_topics.yaml not accessible — treated as empty"
run_history_cross_reference: "data/run_history.yaml not accessible — recurring theme check unavailable this run"

notes: >
  Strongest signal day in food safety this cycle — three simultaneous Class I FDA food recalls plus
  an active E. coli outbreak investigation. Both P1 briefs are publish-immediately; the key editorial
  pre-publish gate is confirming FDA recall notice URLs for the eye drops and cream cheese/seasoning
  (primary URLs not directly retrieved in this session due to tool access constraints — must verify
  manually at fda.gov/safety/recalls-market-withdrawals-safety-alerts before any product/lot code
  information is published).

  Gut health trend spike (+40 in 7 days, 95/100) is the most analytically interesting signal — it is
  not driven by a single news event but by genuine consumer search behavior across multiple specific
  queries (stewed apples, seed probiotics, mushroom coffee, GI map tests). This represents a durable
  content opportunity with a strong differentiation angle vs. supplement-marketing-dominated SERP.

  McConnell health queries are among the top rising terms in Google Trends today but are entirely
  political in nature — no editorial action warranted; rejected appropriately.

  The psilocybin/cocaine RCT was the only candidate that required P5/Monitor routing from Skill 02b.
  The Red Light Holland press release lacks independent peer-reviewed publication identification.
  If a DOI or journal publication emerges, this candidate can be re-evaluated.
```

---

*Dashboard compiled: 2026-07-10 | Pipeline: Skills 01–12 complete | All 9 retained candidates briefed | Integrity flags consolidated | Run archived above*